Xiangting Jin Min Yan Fanfan Li
10.3389/fonc.2022.1059670
Front Oncol
2022 Dec 8;12:1059670.
breast cancer dose adjustment end-stage renal disease peritoneal dialysis pyrotinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/36568221/
Case Reports
PMC9780055
36568221
Durable effect of pyrotinib plus capecitabine in HER-2+ breast cancer patient undergoing peritoneal dialysis: A case report and literature review
2022